124 related articles for article (PubMed ID: 8623251)
1. Inhibition of complement-mediated porcine endothelial cell cytotoxicity by human IgM natural antibody.
Dalmasso AP; He T; Benson BA
Transplant Proc; 1996 Apr; 28(2):535. PubMed ID: 8623251
[No Abstract] [Full Text] [Related]
2. The role of cell-surface glycoproteins in the activation of endothelial cells by antibody and complement.
Lindman BJ; Noreen HJ; Geller RL; Dalmasso AP; Bach FH; Platt JL
Transplant Proc; 1992 Apr; 24(2):586-7. PubMed ID: 1566439
[No Abstract] [Full Text] [Related]
3. Fixation of mammalian natural antibodies to porcine endothelial cells.
Hammer C; Höbel G; Csapo C
Transplant Proc; 1992 Apr; 24(2):588-9. PubMed ID: 1566440
[No Abstract] [Full Text] [Related]
4. Inhibition of primates performed xenoantibody binding to pig aortic endothelial cells and its potential application to xenotransplantation.
Kwiatkowski P; Mazurek AP; Rowiński W; Fiedor P
Acta Pol Pharm; 1997; 54(1):43-7. PubMed ID: 9415198
[TBL] [Abstract][Full Text] [Related]
5. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells.
Laumonier T; Walpen AJ; Maurus CF; Mohacsi PJ; Matozan KM; Korchagina EY; Bovin NV; Vanhove B; Seebach JD; Rieben R
Transplantation; 2003 Sep; 76(5):838-43. PubMed ID: 14501864
[TBL] [Abstract][Full Text] [Related]
6. A study of soluble HLA-G1 protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity.
Zeng MH; Fang CY; Wang SS; Zhu M; Xie L; Li R; Wang L; Wu XW; Chen S
Transplant Proc; 2006 Dec; 38(10):3312-4. PubMed ID: 17175258
[TBL] [Abstract][Full Text] [Related]
7. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D
Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908
[No Abstract] [Full Text] [Related]
8. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
9. Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells.
Vanhove B; Bach FH
Transplantation; 1993 Nov; 56(5):1251-3. PubMed ID: 8249132
[No Abstract] [Full Text] [Related]
10. Oxidant stress increases susceptibility of porcine endothelial cells to injury by xenoreactive antibody and complement.
Magee JC; Platt JL; Oldham KT; Guice KS
Transplant Proc; 1994 Jun; 26(3):1170. PubMed ID: 8029874
[No Abstract] [Full Text] [Related]
11. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Galalpha1,3Gal-based xenoantigens.
Sumitran S; Liu J; Czech KA; Christensson B; Widner H; Holgersson J
Exp Neurol; 1999 Oct; 159(2):347-61. PubMed ID: 10506507
[TBL] [Abstract][Full Text] [Related]
12. Human complement-activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation.
Saethre M; Lea T; Borgen MS; Fiane AE; Michaelsen TE; Thorsby E; Haraldsen G; Mollnes TE
Xenotransplantation; 2006 May; 13(3):215-23. PubMed ID: 16756564
[TBL] [Abstract][Full Text] [Related]
13. Variation in expression of porcine antigens recognized by human xenoreactive natural antibodies.
Cotterell AH; Alvarado CG; Logan JS; Platt JL
Transplant Proc; 1995 Feb; 27(1):278-9. PubMed ID: 7879002
[No Abstract] [Full Text] [Related]
14. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
[No Abstract] [Full Text] [Related]
15. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood.
Banz Y; Cung T; Korchagina EY; Bovin NV; Haeberli A; Rieben R
Xenotransplantation; 2005 Nov; 12(6):434-43. PubMed ID: 16202066
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated cytotoxicity to porcine aortic endothelial cells is not dependent on galactosyl residues when baboon peripheral blood lymphocytes are previously primed with pig xenoantigens.
Dehoux JP; Nizet Y; de la Parra B; Lecuivre C; Vergauwen M; Bazin H; Latinne D; Gianello P
Transplantation; 2003 Dec; 76(12):1675-80. PubMed ID: 14688514
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional analysis of human natural anti-pig xenoantibodies.
Xu H; Edwards N; Chen JM; Dong X; Kaplon RJ; Kwiatkowski P; Michler RE
Transplant Proc; 1994 Jun; 26(3):1365-8. PubMed ID: 8029943
[No Abstract] [Full Text] [Related]
18. Activation of endothelial cells in hyperacute xenograft rejection.
Geller RL; Bach FH; Vercellotti GM; Nistler RS; Bolman RM; Fischel RJ; Leventhal J; Platt JL
Transplant Proc; 1992 Apr; 24(2):592. PubMed ID: 1566442
[No Abstract] [Full Text] [Related]
19. Characterization of human antibodies that are cytotoxic to pig aortic endothelial cells.
Tuso PJ; Cramer DV; Cosenza CA; Middleton YD; Yasunaga C; Wu GD; Makowka L
Transplant Proc; 1993 Feb; 25(1 Pt 1):392-3. PubMed ID: 8438350
[No Abstract] [Full Text] [Related]
20. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells.
Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE
Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
